AstraZeneca and 4D Molecular Therapeutics explore gene therapy for lung disease
AstraZeneca and 4D Molecular Therapeutics have formed a collaboration to develop a gene therapy for patients with chronic lung disease.
AstraZeneca and 4D Molecular Therapeutics have formed a collaboration to develop a gene therapy for patients with chronic lung disease.
Researchers from MIT have devised a way for T cells to be engineered to carry nanoparticle ‘backpacks’ that can deliver the payload only when interacting with the target tumour cells.
Cell for Cure will make Novartis’ CAR T-cell treatments in France, in anticipation of Kymriah’s regulatory approval in Europe.